Boston Biomedical, Inc.
Records under this name other than the patents Boston Biomedical, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 1 patents it holds.
Back to Boston Biomedical, Inc.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,710,057 | Imidazo[1,2-b]pyridazine and Pyrazolo[1,5-a]pyrimidine Derivatives and Their Use as Protein Kinase Inhibitors Formerly held In force · High confidence | In force | High confidence | |
| US 7,750,007 | Imidazo[1,2-beta]pyridazine and PYRAZOLO[1,5-Alpha]PYRIMIDINE Derivatives and Their Use as Protein Kinase Inhibitors Formerly held In force · High confidence | In force | High confidence | |
| US 9,481,884 | Enabling the use of long dsRNA for gene targeting in mammalian and other selected animal cells Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 10,927,376 | Compositions of Asymmetric Interfering RNA and Uses Thereof Formerly held In force · Medium confidence | In force | Medium confidence | |
| US 11,015,195 | Compositions of Asymmetric Interfering RNA and Uses Thereof Formerly held In force · Medium confidence | In force | Medium confidence | |
| US 12,344,840 | Compositions of Asymmetric Interfering RNA and Uses Thereof Formerly held In force · Medium confidence | In force | Medium confidence | |
| US 9,328,345 | Compositions of Asymmetric Interfering RNA and Uses Thereof Formerly held In force · High confidence | In force | High confidence | |
| US 9,416,132 | Substituted imidazo[1,2-b]pyridazines as protein kinase inhibitors Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 10,047,093 | Substituted imidazo[1,2-B]pyridazines as protein kinase inhibitors Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 10,392,392 | Substituted imidazo[1,2-B]pyridazines as protein kinase inhibitors Formerly held In force · From the USPTO record | In force | From the USPTO record |